Heritability of the severity of diabetic retinopathy: The FIND-Eye study

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 9, 2008, Pages 3839-3845

  Arar, Nedal H ^a   Freedman, Barry I ^a   Adler, Sharon G ^a   Iyengar, Sudha K ^a   Chew, Emily Y ^a   Davis, Mathew D ^a   Satko, Scott G ^a   Bowden, Donald W ^a   Duggirala, Ravi ^a   Elston, Robert C ^a   Guo, Xiuxing ^a   Hanson, Robert L ^a   Igo Jr , Robert P ^a   Ipp, Eli ^a   Kimmel, Paul L ^a   Knowler, William C ^a   Molineros, Julio ^a   Nelson, Robert G ^a   Pahl, Madeleine V ^a   Quade, Shannon R E ^a   Rasooly, Rebekah S ^a   Rotter, Jerome I ^a   Saad, Mohammed F ^a   Scavini, Marina ^a   Schelling, Jeffrey R ^a   Sedor, John R ^a   Shah, Vallabh O ^a   Zager, Philip G ^a   Abboud, Hanna E ^a   more..

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AFRICAN AMERICAN; AMERICAN INDIAN; ARTICLE; CLINICAL EVALUATION; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ETHNICITY; EUROPEAN AMERICAN; EYE EXAMINATION; FAMILY; FAMILY HISTORY; FEMALE; HERITABILITY; HISPANIC; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SIBLING; BLOOD; DIABETIC ANGIOPATHY; ETHNIC GROUP; FLUORESCENCE ANGIOGRAPHY; GENETICS; HOSPITALIZATION; MICROCIRCULATION; PATHOPHYSIOLOGY; PHENOTYPE; RACE;

CONTINENTAL POPULATION GROUPS; CREATININE; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; ETHNIC GROUPS; FAMILY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MALE; MICROCIRCULATION; PHENOTYPE; SEVERITY OF ILLNESS INDEX; SIBLINGS;

EID: 53149130213     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1633     Document Type: Article

References (50)

1. West K, Erdreich L, Stober J. A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes. 1980;29:501-508. (Pubitemid 12180506)
2. Stratton IM, Kohner EM, Aldington SJ, et al.; UKPDS Group. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia. 2001;44:156-163.
3. Kempen J, O'Colmain B, Leske M, et al.; Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):552-563.
4. Fong D, Aiello L, Gardner T, et al. Retinopahty in diabetes (position statement). Diabetes Care. 2004;27(suppl 1):S84-S87.
5. Klein R, Klein BE, Moss SE, Davis DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102:520-526.
6. Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A. Epidemiology of diabetic retinopathy and macular edema: a systematic review. Eye. 2004;18:963-983. (Pubitemid 39430033)
7. Early Treatment Diabetic Retinopathy Study Research Group (ETDRS). Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House classification. Ophthalmology. 1991;98:786-806.
8. Estacio RO, McFarling E, Biggerstaff S, Jeffers BW, Johnson D, Schrier RW. Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. Am J Kidney Dis. 1998;31:947-953. (Pubitemid 28265190)
9. Velho G, Vaxillaire M, Boccio V, Charpentier G, Froguel P. Diabetes complications in NIDDM kindreds linked to the MODY3 locus on chromosome 12q. Diabetes Care. 1996;19:915-919. (Pubitemid 26301224)
10. Harris M, Klein R, Cowie C, Rowland M, Byrd-Holt D. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care. 1998;21:1230-1235. (Pubitemid 28365675)
11. Hallman M, Huber C, Gonzalez V, Klein B, Klein R, Hanis C. Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. Diabetes Care. 2005;28:1163-1168.
12. Tudor SM, Hamman RF, Baron A, Johson DW, Shetterly SM. Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes. San Luis Valley Diabetes Study, Colorado. Diabetes Care. 1998;21:53-61. (Pubitemid 28030386)
13. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342:381-389.
14. Rema M, Saravanan G, Deepa R, Mohan V. Familial clustering of diabetic retinopathy in South Indian type 2 diabetic patients. Diabet Med. 2002;19:910-916. (Pubitemid 35356916)
15. US Renal Data System: USRDS 2006 Annual Data Report: Atlas of End Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006.
16. Freedman B, Langefeld C, Rich S, et al. A genome scan for ESRD in black families enriched for nondiabetic nephropathy. J Am Soc Nephrol. 2004;15:2719-2727. (Pubitemid 41103379)
17. Imperatore G, Hanson R, Pettitt D, Kobes S, Bennett P, Knowler W. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes. 1998;47:821-830.
18. Imperatore G, Knowler W, Pettitt D, et al. Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes. 2000;49:1049-1056. (Pubitemid 30349429)
19. Krolewski AS, Poznik GD, Placha G, et al. A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int. 2006;69:129-136. (Pubitemid 43117748)
20. Forsblom CM, Kanninen T, Lehtovirta M, Saloranta C, Groop LC. Heritability of albumin excretion rate in families of patients with Type II diabetes. Diabetologia. 1999;42(11):1359-1366. (Pubitemid 29500974)
21. Freedman B, Beck S, Rich S, et al. A genome-wide scan for urinary albumin excretion in hypertensive families. Hypertension. 2003;42:291-296. (Pubitemid 37093475)
22. Trevisan R, Vedovato M, Mazzon C, et al. Concomitance of diabetic retinopathy and proteinuria accelerates the rate of decline of kidney function in type 2 diabetic patients. Diabetes Care. 2002;25(11):2026-2031. (Pubitemid 41071063)
23. Knowler WC, Coresh J, Elston RC, et al.; Family Investigation of Nephropathy and Diabetes Research Group. The Family Investigation of Nephropathy and Diabetes (FIND): design and methods. J Diabetes Complications. 2005;19:1-9.
24. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183-1197. (Pubitemid 27274286)
25. Early Treatment Diabetic Retinopathy Study Research Group. Fundus Photographic Risk Factors for Progression of Diabetic Retinopathy ETDRS Report Number 12. Ophthalmology. 1991;98:823-833.
26. Looker HC, Krakoff J, Knowler WC, Bennett PH, Klein R, Hanson RL. Longitudinal studies of incidence and progression of diabetic retinopathy assessed by retinal photography in Pima Indians. Diabetes Care. 2003;26:320-326. (Pubitemid 36929049)
27. Mendel NR, Elston R. Multifactorial qualitative traits: genetic analyses and prediction of recurrence risks. Biometrics. 1974;30:41-57.
28. Fisher RA. Statistical Methods for Research Workers. 11th ed.; 1950;288-292.
29. SAGE. Statistical Analysis for Genetic Epidemiology. Release 4.0. 2001. Cleveland, OH: Case Western Reserve University, Department of Epidemiology and Biostatistics, Rammelkamp Center for Education and Research, MetroHealth Campus.
30. Keen KJ, Elston RC. Robust asymptotic sampling theory for correlations in pedigrees. Stat Med. 2003;22:3229-3247.
31. Falconer DS, Mackay TF. Introduction to Quantitative Genetics. Essex, UK: Longman; 1996.
32. Looker HC, Nelson RG, Chew E, et al. Genome-wide linkage analyses to identify loci for diabetic retinopathy. Diabetes. 2007;56(4):1160-1166. (Pubitemid 46525074)
33. Manaviat MR, Afkhami M, Shoja MR. Retinopathy and microalbuminuria in type II diabetic patients. BMC Ophthalmol. 2004;1:4-9. (Pubitemid 39258904)
34. Jones CA, Francis ME, Eberhardt MS, et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2002;39:445-459. (Pubitemid 34194620)
35. Pugh JA, Stern MP, Haffner SM, Eifler CW, Zapata M. Excess incidence of treatment of end-stage renal disease in Mexican Americans. Am J Epidemiol. 1988;127(1):135-144. (Pubitemid 18034374)
36. Haffner SM, Mitchell BD, Pugh JA, et al. Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM. Diabetes Care. 1989;12:530-536.
37. Hallman D, Boerwinkle E, Gonzalez V, Klein B, Klein R, Hanis C. A genome-wide linkage scan for diabetic retinopathy susceptibility genes in Mexican Americans with type 2 diabetes from Starr County. Texas Diabetes. 2007;56(4):1167-1173. (Pubitemid 46525075)
38. Silbiger S, Neugarten J. The impact of gender on the progression of chronic renal disease. Am J Kidney Dis. 1995;25:515-533.
39. Guccione M, Silbiger S, Lei J, Neugarten J. Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2. Am J Physiol. 2002;282(1):F164-F169. (Pubitemid 34654211)
40. Neugarten J, Ding Q, Friedman A, Lei J, Silbiger S. Sex hormones and renal nitric oxide synthases. J Am Soc Nephrol. 1997;8(8):1240-1246. (Pubitemid 27493628)
41. Klein R, Davis Moss SE, Klein BE, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: a comparison of retinopathy in younger and older onset diabetic persons. Adv Exp Med Biol. 1985;189:321-335.
42. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: The Chennai Urban Rural Epidemiology Study (CURES)Eye Study, I. Invest Ophthalmol Vis Sci. 2005;46:2328-2333.
43. Forsblom CM, Groop PH, Ekstrand A, Groop LC. Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration (see comments). BMJ. 1992;305:1051-1053.
44. Varma R, Macias GL, Torres M, Klein R, Peña FY, Azen SP. Los Angeles Latino Eye Study Group. Biologic risk factors associated with diabetic retinopathy: the Los Angeles Latino Eye Study. Ophthalmology. 2007;114(7):1332-1340.
45. Wong TY, Klein R, Islam FM, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol. 2006;141(3):446-455. (Pubitemid 43265947)
46. Inaba M, Okuno S, Kumeda Y, et al.; Osaka CKD Expert Research Group. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol. 2007;18(3):896-903. (Pubitemid 46434506)
47. Imperatore G, Knowler WC, Nelson R, Hanson R. Genetics of diabetic nephropathy in the Pima Indians. Curr Diab Rep. 2001;1:275-281.
48. Falck A, Knip J, Ilonen J, Laatikainen L. Genetic markers in early diabetic retinopathy of adolescents with type I diabetes. J Diabetes Complications. 1997;11:203-207. (Pubitemid 27271901)
49. Uhlmann K, Kovacs P, Boettcher Y, Hammes HP, Paschke R. Genetics of diabetic retinopathy. Exp Clin Endocrinol Diabetes. 2006;114(6):275-294.
50. Iyengar SK, Abboud HE, Goddard KA, et al. Genome-wide scans for diabetic nephropathy and albuminuria in multi-ethnic populations: The Family Investigation of Nephropathy and Diabetes. Diabetes. 2007;56(6):1577-1587.